These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23836623)

  • 1. Authors' reply.
    Sozu T; Sugimoto T; Hamasaki T
    Biom J; 2013 Sep; 55(5):813. PubMed ID: 23836623
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor.
    Wu B; de Leon AR
    Biom J; 2013 Sep; 55(5):807-12. PubMed ID: 23754190
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of composite endpoints in clinical trials.
    Sankoh AJ; Li H; D'Agostino RB
    Stat Med; 2016 Jan; 35(2):319-20. PubMed ID: 26767752
    [No Abstract]   [Full Text] [Related]  

  • 4. ALS endpoints. Survival.
    Cedarbaum J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():79-83. PubMed ID: 15512880
    [No Abstract]   [Full Text] [Related]  

  • 5. End points in advanced colon cancer clinical trials: a review and proposal.
    Allegra C; Blanke C; Buyse M; Goldberg R; Grothey A; Meropol NJ; Saltz L; Venook A; Yothers G; Sargent D
    J Clin Oncol; 2007 Aug; 25(24):3572-5. PubMed ID: 17704403
    [No Abstract]   [Full Text] [Related]  

  • 6. Surrogate end points, skepticism, and the CAST study.
    Thompson DF
    Ann Pharmacother; 2002 Jan; 36(1):170-1. PubMed ID: 11816249
    [No Abstract]   [Full Text] [Related]  

  • 7. Strong control over multiple endpoints: are we adding value to the assessment of medicines?
    Stone A; Chuang-Stein C
    Pharm Stat; 2013; 12(4):189-91. PubMed ID: 23703978
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on 'Use of composite endpoints in clinical trials' by Abdul J. Sankoh, Haihong Li and Ralph B. D'Agostino, Sr.
    Gómez G; Gómez-Mateu M
    Stat Med; 2016 Jan; 35(2):317-8. PubMed ID: 26767751
    [No Abstract]   [Full Text] [Related]  

  • 9. A collaborative model for endpoint development for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia.
    Toerner JG; Burke L; Komo S; Papadopoulos E
    Clin Infect Dis; 2012 Oct; 55(8):1122-3. PubMed ID: 22744886
    [No Abstract]   [Full Text] [Related]  

  • 10. Surrogate and mediating endpoints: current status and future directions.
    Prentice RL
    J Natl Cancer Inst; 2009 Feb; 101(4):216-7. PubMed ID: 19211455
    [No Abstract]   [Full Text] [Related]  

  • 11. Interim analyses in clinical trials: why do we plan them?
    Fossâ SD; Skovlund E
    J Clin Oncol; 2000 Dec; 18(24):4007-8. PubMed ID: 11118460
    [No Abstract]   [Full Text] [Related]  

  • 12. Examining the Influence of Component Outcomes on the Composite at the Design Stage.
    Brown PM; Ezekowitz JA
    Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004419. PubMed ID: 29860234
    [No Abstract]   [Full Text] [Related]  

  • 13. Dealing with multiple endpoints.
    Dueck A; Novotny PJ
    Curr Probl Cancer; 2006; 30(6):298-306. PubMed ID: 17123881
    [No Abstract]   [Full Text] [Related]  

  • 14. Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
    Waxman AB; Farber HW
    Circulation; 2015 Dec; 132(22):2152-61. PubMed ID: 26621638
    [No Abstract]   [Full Text] [Related]  

  • 15. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Note on simultaneous inferences about non-inferiority and superiority for a primary and a secondary endpoint.
    Guilbaud O
    Biom J; 2011 Nov; 53(6):927-37. PubMed ID: 22002473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hotel-based rheumatology, and more.
    Leeb BF
    J Rheumatol; 2009 Feb; 36(2):455-6; author reply 456-7. PubMed ID: 19208582
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of central event adjudication.
    Kerr DR; Nasco E
    Stroke; 2009 Nov; 40(11):e638; author reply e639-40. PubMed ID: 19762697
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple analyses in clinical trials: sound science or data dredging?
    Lord SJ; Gebski VJ; Keech AC
    Med J Aust; 2004 Oct; 181(8):452-4. PubMed ID: 15487966
    [No Abstract]   [Full Text] [Related]  

  • 20. You get what you measure: evaluating endpoints in MS clinical trials.
    Marrie RA
    Neurology; 2008 Aug; 71(9):620-1. PubMed ID: 18685132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.